HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics of cutaneous lymphomas in Korea.

Abstract
The clinicopathologic characteristics of malignant lymphomas vary according to geography. The aim of this study was to determine the relative frequency of cutaneous lymphomas and to examine the clinical relevance of the WHO classification in Korean cases of cutaneous lymphoma. The Korean Dermatopathology Research Group conducted a clinicopathologic review of a nationwide collection of 80 cutaneous lymphomas, diagnosed at 23 institutes over a recent 3-year period. The clinical records, haematoxylin & eosin-stained slides and immunohistochemical stains from 80 patients with malignant lymphomas of the skin were reviewed. In our study, the most frequent cutaneous lymphoma was mycosis fungoides. Compared with Western countries, Korea had higher rates of NK/T cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma and a much lower rate of B-cell lymphoma. The occurrence rates for various subtypes of malignant lymphoma in Korea are distinct from those in Western countries. The EORTC classification is not fully appropriate in dealing with Korean cases of cutaneous lymphoma, because NK/T cell lymphoma is not included in the EORTC classification for cutaneous lymphoma.
AuthorsM-W Lee, Korean Dermatopathology Research Group
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 28 Issue 6 Pg. 639-46 (Nov 2003) ISSN: 0307-6938 [Print] England
PMID14616833 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Female
  • Humans
  • Immunophenotyping (methods)
  • Incidence
  • Korea (epidemiology)
  • Lymphoma, B-Cell (classification, epidemiology)
  • Lymphoma, T-Cell, Cutaneous (classification, epidemiology)
  • Male
  • Middle Aged
  • Skin Neoplasms (classification, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: